Wellington Management Group LLP Acquires 8,423,475 Shares of Haleon plc (NYSE:HLN)

Wellington Management Group LLP grew its position in shares of Haleon plc (NYSE:HLN) by 164.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,542,346 shares of the company’s stock after purchasing an additional 8,423,475 shares during the quarter. Wellington Management Group LLP owned about 0.29% of Haleon worth $111,454,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. raised its holdings in Haleon by 19.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,813,997 shares of the company’s stock worth $39,619,000 after purchasing an additional 772,829 shares during the last quarter. Syon Capital LLC raised its holdings in Haleon by 31.4% during the 4th quarter. Syon Capital LLC now owns 67,711 shares of the company’s stock worth $557,000 after purchasing an additional 16,175 shares during the last quarter. Clear Street Markets LLC raised its holdings in Haleon by 13,646.0% during the 4th quarter. Clear Street Markets LLC now owns 13,746 shares of the company’s stock worth $113,000 after purchasing an additional 13,646 shares during the last quarter. Personal CFO Solutions LLC raised its holdings in Haleon by 17.8% during the 4th quarter. Personal CFO Solutions LLC now owns 20,600 shares of the company’s stock worth $170,000 after purchasing an additional 3,115 shares during the last quarter. Finally, Morningstar Investment Services LLC raised its holdings in Haleon by 106.3% during the 4th quarter. Morningstar Investment Services LLC now owns 24,001 shares of the company’s stock worth $199,000 after purchasing an additional 12,367 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

HLN has been the subject of several recent analyst reports. Berenberg Bank initiated coverage on shares of Haleon in a research report on Wednesday, June 5th. They set a “buy” rating for the company. Argus reaffirmed a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. Finally, HSBC initiated coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a “buy” rating for the company. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Haleon Trading Up 0.7 %

NYSE HLN opened at $8.52 on Friday. The stock has a market capitalization of $38.90 billion, a price-to-earnings ratio of 28.40, a PEG ratio of 2.25 and a beta of 0.26. Haleon plc has a one year low of $7.70 and a one year high of $8.96. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The business’s fifty day moving average is $8.36 and its 200-day moving average is $8.33.

Haleon (NYSE:HLN) last released its earnings results on Wednesday, May 1st. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. The company had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.71 billion. Haleon had a return on equity of 13.17% and a net margin of 9.68%. Equities research analysts predict that Haleon plc will post 0.46 EPS for the current year.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.